About ImmunoBiochem
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to address significant unmet need in oncology and immuno-oncology. ImmunoBiochem is unravelling unique biology in the tumor microenvironment with the goal of discovering novel therapeutic targets and strategies. ImmunoBiochem, a Johnson & Johnson Innovation (JLABS) alumnus, is headquartered in Toronto, at the heart of Canada’s largest biomedical research hub.